Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Thickeners and Stabilizers
Lubricants & Glidants
Co-Processed Excipients
Coating Systems & Additives
Disintegrants & Superdisintegrants
Granulation
Taste Masking
Empty Capsules
Controlled & Modified Release
Chewable & Orodispersible Aids
Film Formers & Plasticizers
Emulsifying Agents
Coloring Agents
API Stability Enhancers
Topical
Surfactant & Foaming Agents
Rheology Modifiers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A MECLOFENAMATE SODIUM manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MECLOFENAMATE SODIUM, including repackagers and relabelers. The FDA regulates MECLOFENAMATE SODIUM manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MECLOFENAMATE SODIUM API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of MECLOFENAMATE SODIUM manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A MECLOFENAMATE SODIUM supplier is an individual or a company that provides MECLOFENAMATE SODIUM active pharmaceutical ingredient (API) or MECLOFENAMATE SODIUM finished formulations upon request. The MECLOFENAMATE SODIUM suppliers may include MECLOFENAMATE SODIUM API manufacturers, exporters, distributors and traders.
click here to find a list of MECLOFENAMATE SODIUM suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A MECLOFENAMATE SODIUM DMF (Drug Master File) is a document detailing the whole manufacturing process of MECLOFENAMATE SODIUM active pharmaceutical ingredient (API) in detail. Different forms of MECLOFENAMATE SODIUM DMFs exist exist since differing nations have different regulations, such as MECLOFENAMATE SODIUM USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A MECLOFENAMATE SODIUM DMF submitted to regulatory agencies in the US is known as a USDMF. MECLOFENAMATE SODIUM USDMF includes data on MECLOFENAMATE SODIUM's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MECLOFENAMATE SODIUM USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of MECLOFENAMATE SODIUM suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MECLOFENAMATE SODIUM as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for MECLOFENAMATE SODIUM API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture MECLOFENAMATE SODIUM as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain MECLOFENAMATE SODIUM and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MECLOFENAMATE SODIUM NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of MECLOFENAMATE SODIUM suppliers with NDC on PharmaCompass.
MECLOFENAMATE SODIUM Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of MECLOFENAMATE SODIUM GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right MECLOFENAMATE SODIUM GMP manufacturer or MECLOFENAMATE SODIUM GMP API supplier for your needs.
A MECLOFENAMATE SODIUM CoA (Certificate of Analysis) is a formal document that attests to MECLOFENAMATE SODIUM's compliance with MECLOFENAMATE SODIUM specifications and serves as a tool for batch-level quality control.
MECLOFENAMATE SODIUM CoA mostly includes findings from lab analyses of a specific batch. For each MECLOFENAMATE SODIUM CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
MECLOFENAMATE SODIUM may be tested according to a variety of international standards, such as European Pharmacopoeia (MECLOFENAMATE SODIUM EP), MECLOFENAMATE SODIUM JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MECLOFENAMATE SODIUM USP).
LOOKING FOR A SUPPLIER?
